EGFR and infection: In addition to the impact of long-term antibiotic therapy on gut microbiome in patients receiving EGFR inhibitors, modifications of skin microbiome due to infections that complicate dermatologic toxic effects associated with EGFR inhibitors may also represent a subject of interest for further research.